The Efficiency of Metacognitive Therapy on Improving Physiological (Systolic and Diastolic Blood Pressure) and Psychological (Depression, Stress, Anxiety) Functions in Patients with Primary Hypertension

Document Type : Research Paper

Authors

1 Ph.D. student in psychology, Urmia Branch, Islamic Azad University, Urmia, Iran.

2 Assistant Professor, Department of Psychology, Urmia Branch, Islamic Azad University, Urmia, Iran.

3 Associate Professor, Department of Psychology, Urmia Branch, Islamic Azad University, Urmia, Iran.

Abstract

The present paper aims to investigate the efficiency of metacognitive therapy in improving physiological (systolic and diastolic blood pressure) and psychological (depression, stress, anxiety) performance in patients with primary hypertension. The research method was semi-experimental with a pre-test-post-test design with a control group. However, the statistical population of the study included all men with primary hypertension who had visited the Shams Clinic, located in Bonab city, in the first half of 2020. The research sample consisted of 40 individuals who were selected voluntarily and then randomly assigned to 2 groups of 20 people (experimental group and control group). Furthermore, for the experimental group, metacognition therapy was held in nine sessions of 90 minutes and one session per week. Depression, anxiety, stress scale, and blood pressure measuring device were used to collect the data. multivariate analysis of covariance (MANCOVA) was applied to analyze the data. The findings showed that, however, metacognitive therapy led to significant differences between groups in anxiety, stress, systolic pressure, and diastolic pressure (P<0.01). In other words, metacognitive therapy led to the reduction of anxiety and stress and the improvement of physiological function (systolic and diastolic blood pressure) in the subjects of the experimental group compared to the control group (P<0.01); although the difference between the mean scores of the two groups in the depression component was not significant (P>0.05). Therefore, as the results, it is suggested to apply this treatment method to improve psychological conditions and consequently reduce the physical problems of individuals with primary blood pressure

Keywords

Main Subjects

References

افضلی، علی و فرخزادیان، علی اصغر. (1397). بررسی اثربخشی درمان فراشناختی (MCT) در تغییر سطح رضایت جنسی، رضایت زناشویی و نگرانی از تصویر بدنی در کارمندان زن متأهل مبتلا به افسردگی. فصلنامه علمی-پژوهشی روانشناسی بالینی و شخصیت، 16 (2)، 113-121.
باقریان، رضا؛ باغبانیان، علی؛ خیرآبادی، غلامرضا؛ حیدری نژاد، دامون و مشکاتی، محمدعلی. (1389). مقایسه شیوع علایم افسردگی در بیماران مبتلا به فشار خون بالا و افراد سالم (چکیده دهمین همایش پیاپی سالیانه انجمن علمی روانپزشکان ایران). مجله روانپزشکی و روانشناسی بالینی ایران، 16 (3)، 279-282.
بختیاری، آزاده؛ عابدی، احمد. (1392). اثربخشی درمان گروهی بر پایه الگو فراشناختی ذهن آگاهی انفصالی بر افسردگی و فشارخون بیماران زن مبتلا به فشارخون. پژوهش های روانشناسی بالینی و مشاوره، 3 (2)، 36-23.
حدادی، سمیرا؛ ملیحی الذاکرینی، سعید؛ تاج بخش، رامین؛ تجویدی، منصوره و  کاکاوند، علیرضا. (1399). مقایسه اثربخشی درمان مبتنی بر تعهد و پذیرش و فراشناخت‌درمانی بر فشار خون، در بیماران تحت همودیالیز. مجله دانشگاه علوم پزشکی قم, 15(1), 10-19.‎
صاحبی، علی؛ اصغری، محمدجواد و سالاری، راضیه سادات. (1384). اعتباریابی مقیاس افسردگی اضطراب تنیدگی(DASS-21)  برای جمعیت ایرانی. روانشناسی تحولی، 1(4)، 1-18.
غلامرضایی، سیمین؛ یوسف وند، مهدی؛ غضنفری، فیروزه و فرخ زادیان، علی اصغر. (1396). اثربخشی درمان فراشناختی (MCT) در تغییر سطح باورهای فراشناختی و نگرانی تصویربدنی دانش آموزان افسرده. نشریه علمی-پژوهشی آموزش وارزشیابی، 10 (40)، 127-105.
قربانی، زهرا. (1398). اثربخشی درمان فراشناختی MCT بر درآمیختگی افکار و کیفیت زندگی سالمندان مبتلا به افسردگی در شهرستان کرمانشاه در سال 1398، سومین همایش ملی روانشناسی، تعلیم و تربیت و سبک زندگی، قزوین.
محمودعلیلو، مجید و لشگری، آرزو. (1399). اثربخشی درمان فراشناختی (MCT) بر کاهش نگرانی و فرانگرانی افراد دارای نشانه های اختلال اضطراب فراگیر (GAD). فصلنامه پژوهش­های نوین روانشناختی، 15(59)، 187-197.
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) Washington, DC: American Psychiatric Association.
Borders, A. (2020). Metacognitive therapy for rumination. Rumination and Related Constructs, Causes, Consequences, and Treatment of Thinking. Too Much,
Capobianco, L., Reeves, D., Morrison, A. P., & Wells, A. (2018). Group metacognitive therapy vs. mindfulness meditation therapy in a transdiagnostic patient sample: a randomised feasibility trial. Psychiatry research, 259, 554-561.
Chou, C.C., Chien, L. Y., Lin, M.F., & Wang, C. J. (2021). Cognitive function and associated factors among postmenopausal women with hypertension and natural menopause in Taiwan. Geriatric Nursing, 42(1), 110-116.
Countouris, M. E., Jeyabalan, A., Caldwell, J. C., Lee, J. E., & Hickey, G. W. (2020). Primary Presentation of Pulmonary Hypertension in the Peripartum: Preparing for Patients With Eisenmenger Physiology. Case Reports, 2(1), 125-130.
De Dominicis, S., Troen, M. L., & Callesen, P. (2021). Metacognitive Therapy for Work-Related Stress: A Feasibility Study. Frontiers in Psychiatry, 12, 794.
Emdin, C. A., Rothwell, P. M., Salimi-Khorshidi, G., Kiran, A., Conrad, N., Callender, T., & Rahimi, K. (2016). Blood pressure and risk of vascular dementia: evidence from a primary care registry and a cohort study of transient ischemic attack and stroke. Stroke, 47(6), 1429-1435
Endres, M., Heuschmann, P. U., Laufs, U., & Hakim, A. M. (2011). Primary prevention of stroke: blood pressure, lipids, and heart failure. European heart journal, 32(5), 545-552
Ermayani, M., Prabawati, D., & Susilo, W. H. (2020). The effect of progressive muscle relaxation on anxiety and blood pressure among hypertension patients in east Kalimantan, Indonesia. Enfermería Clínica, 30, 121-125.
Hallowell, E. M., & Ratey, J. (2005). Delivered from Distraction: Getting the Most out of Life with Attention Deficit Disorder. Ballentine Books.
Huang, Y., Su, Y., Jiang, Y., & Zhu, M. (2020). Sex differences in the associations between blood pressure and anxiety and depression scores in a middle-aged and elderly population: the Irish Longitudinal Study on Ageing (TILDA). Journal of Affective Disorders, 274, 118-125.
Jelinek, L., Moritz, S., & Hauschildt, M. (2017). Patients’ perspectives on treatment with metacognitive training for depression (D-MCT): results on acceptability. Journal of affective disorders, 221, 17-24.
Kolubinski, D. C., Marino, C., Nikčević, A. V., & Spada, M. M. (2019). A metacognitive model of self-esteem. Journal of affective disorders, 256, 42-53.
Lovibond, F, & Lovibond, SH.(1995) The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behave Res Ther, 33, 335-343.
Matthews, K. A., Katholi, C. R., McCreath, H., Whooley, M. A., Williams, D. R., Zhu, S. (2004). Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation, 110(1), 74-78.
McEvoy, P.M. (2019). Metacognitive Therapy for Anxiety Disorders: a Review of Recent Advances and Future metacognitive therapy vs applied relaxation in the treatment of adults with generalized anxiety disorder. Behavioral research and therapy, 48, 429-434.
Michalsen, A., Grossman, P., Lehmann, N., Knoblauch, N. T., Paul, A., Moebus, S., ... & Dobos, G. J. (2005). Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial. Psychotherapy and psychosomatics, 74(6), 344-352.
Naqvi, S., Asar, T.O., Kumar, V., Al-Abbasi, F.A., Alhayyani, S., Kamal, M.A., & Anwar, F. (2021). A cross-talk between gut microbiome, salt and hypertension. Biomedicine & Pharmacotherapy, 134, 111-156.
Park, E., Kim, D., & Choi, S. (2019). The impact of differential cost sharing of prescription drugs on the use of primary care clinics among patients with hypertension or diabetes. Public health, 173, 105-111.
Spada, M. M., Nikčević, A. V., Moneta, G. B., & Wells, A. (2008). Metacognition, perceived stress, and negative emotion. Personality and Individual Differences, 44(5), 1172-1181
Tengilimoğlu, D., Zekioğlu, A., Tosun, N., Işık, O., & Tengilimoğlu, O. (2021). Impacts of COVID-19 pandemic period on depression, anxiety and stress levels of the healthcare employees in Turkey. Legal Medicine, 48, 101811.
Thanalakshmi, J., Maheshkumar, K., Kannan, R., Sundareswaran, L., Venugopal, V., & Poonguzhali, S. (2020). Effect of Sheetali pranayama on cardiac autonomic function among patients with primary hypertension-A randomized controlled trial. Complementary therapies in clinical practice, 39, 101138.
Von Visger, T.T., Kuntz, K.K., Phillips, G.S., Yildiz, V.O., & Sood, N. (2018). Quality of life and psychological symptoms in patients with pulmonary hypertension. Heart & Lung, 47(2), 115-121.
Wells, A. (2000). Emotional Disorders and Metacognition: Innovative Cognitive Therapy. New Jersey: Wilry.
Wells, A. (2008). Met Cognitive Therapy: A Practical Guide. 5t ed. New York, Guilford Press, Chichester, UK: Wiley.
Wells, A., & Colbear, J. S. (2012). Treating posttraumatic stress disorder with metacognitive therapy: a preliminary controlled trial. Journal of clinical psychology, 68(4), 373-381.
Wells, A., Welford, M., King, J., Papagergiou, C., Wisley, J., & Mendal, E. (2010). A pilot randomized trial of Research Directions. Current psychiatry reports, 21(5), 29.
Winter, L., Naumann, F., Olsson, K., Fuge, J., Hoeper, M. M., & Kahl, K. G. (2020). Metacognitive therapy for adjustment disorder in a patient with newly diagnosed pulmonary arterial hypertension: a case report. Frontiers in Psychology, 11, 143.
Yadavari, F. (2017). Investigate the relationship between body intelligence and sensation seeking with the symptoms of migraine headaches in students: The mediating role of emotional control. Islamic Azad University of Tabriz. Tabriz.
Journal of Modern Psychological Researches
Volume 18, Issue 72 - Serial Number 72
December 2023
Pages 153-161

Files

History

  • Receive Date: 19 October 2022
  • Revise Date: 08 December 2022
  • Accept Date: 18 December 2022

Share

How to cite

Statistics